CRS Endometriosis Clinical Research
We are dedicated to revolutionizing treatment approaches for women affected by endometriosis. Our biostatistics and methodology specialists support clinical programs from early development through all study phases, providing strategic guidance for study protocols — including gynecological assessments, sample size determination, study objectives, and endpoint definition — ensuring scientific rigor and alignment with regulatory expectations.
-
Statistical support across the full drug development cycle, from early clinical phases onward
-
Expertise in complex gynecological methodology, adaptive approaches, and handling missing data
- Extensive experience supporting regulatory advisory meetings and clinical trial authorization processes
Our Capabilities
Our comprehensive endometriosis research and study design capabilities include:
- Gynecological Examination
- Transvaginal Ultrasound
- Vaginal Cytology
- Endometrial Biopsy
- Insler Score and Hoogland Score assessments
- Monitoring of Follicular Growth/Ovulation
- Rating Scales/Questionnaires: Assessments for quality of life, sleep quality, and pain levels
- Comprehensive central laboratory partnerships for standardized safety examinations and hormone assays
- Five experienced, board-certified gynecologists conducting in-house examinations
- Specialized providers for analyzing PAP smears and endometrial histology
Why Choose hVIVO?
We deliver the combined strength of a full-service CRO and specialist women's health team to deliver robust and interpretable results. We bring decades of multidisciplinary expertise and a commitment to quality that helps clients control timelines and costs without compromising scientific rigor.
Our state-of-the-art early phase units ensure adherence to Good Clinical Practice (GCP) standards set forth by the FDA and the European Medicines Agency (EMA). Our multidisciplinary team of scientists, medical experts, statisticians, and medical writers tirelessly translates research findings into meaningful advancements that improve the quality of life for patients with endometriosis.
Our state-of-the-art early phase units ensure adherence to Good Clinical Practice (GCP) standards set forth by the FDA and the European Medicines Agency (EMA). Our multidisciplinary team of scientists, medical experts, statisticians, and medical writers tirelessly translates research findings into meaningful advancements that improve the quality of life for patients with endometriosis.